Member Info for Rocky500

Trevor is still in bail out mode with Chamberlin, that's the point of the raise.

It's not that binary with Trevor, ultimately if he needed cash today to settle the Chamberlin placing which is due to list tomorrow then he will take it from here and put it there, irrespective of what news is due here. That's assuming he is able to sell now...if he knew bad news was coming then that's insider trading. He ain't going to get into trouble if he sells before a rise. It just raises the value of his remaining holding.

I don't think it's connected to his thoughts on BRH. If anything he must be assuming selling 2m shares is not going to torpedo the value of the rest. If he needed cash quick then he needed it and by the looks of it needed it today.

Exactly, not BRH.

He's not in partnership with BRH, he's working with Paraytec...which is owned by BRH but they are separate in operations and the fact one is an investment company and the other a scientific company. Carl is not naive like Gareth so will be keeping himself focused on getting the test sorted...which he seems to be doing with distinction...

Not sure if it will crash the price that much as there's nothing subtle about what's just happened and therefore less of a surprise. It does point towards a quick cash call and the dates for chamberlin would tie in with that. Could be coincidental but TB may have been waiting for the anticipated rise before month end.

TB did Tweet yesterday '@Chamberlin' and just that...may be connected to him selling here if in fact it was him. A little cryptic and perhaps unconnected but you never know. Does seem like a urgent need for cash over running for the door tho.

You're an idiot and clearly wanting to be told so...

You do talk so much rubbish it's funny. If it's connected to this it's more likely the product was billed for rollout end of June.

It's unlikely to be that either however as Carl does not communicate in this cryptic investor relations way. He talks science, of which he is increasingly confident and positive about. That was a very poor effort.

Bored of talking to touchy trig, some people are so blinkered they can’t see the big world outside of their own little one. These are people who you can’t have a reasoned conversation with and not worth the time.

Most are calm, reasoned and objective...a few might be a little excitable. You will notice I’m not talking over on AVCT as I’m not invested and don’t think it’s necessary to force my opinion on them. When we get a stray over here for no good reason then that’s different.

Touchy...a true AVCT supporter

AVCT mcap is based so much on presumed success going forward that it wont take much for that pack of cards to come crashing down. At least here there is some value based upon the test, its largely based upon the work done to date and virtually nothing for what could come in the near future.

The AVCT lot are really touchy and always have been...whilst I can see they may have potential their mcap is ridiculous...doesn't take much for a NCYT type crash if there is literally a breeze from the wrong direction...don't see the point in reaching over here and making silly comments...possibly a nervous disposition or complex.

No you dont and you know it as well. You're a wind up merchant who knows full well that if the results are as good as they are being billed to potentially be then this stock is undervalued compared to its peers currently. You have offered no real contribution from what I've seen. I agree there are those who get a little over excited but in this instance it could well be you who cost people money by putting them off investing in what could be a stellar performer over the next few months. I'm not saying it will or won't but the science coming out is very compelling. It was being knocked late last year for being too late but as it turns out its timing could very well be spot on.

You have already contributed to your 'mates' thread which suggested the same so it's a case of following your lead I think.

It's the science that is speaking here, enthusiastically and passionately which is compelling. We as investors know there is a business case for a next gen test solution of this sort, investors need to be confident of the science behind it and that's what Carl is providing. It's not really ramping as such on his part, he is speaking science and it just happens to be relevant.

I suspect we will get that update in the next few weeks (on time) and then it's time to shout as loud as the RMS mob did as that got results...its just RMS couldn't get get the product out on time. If Carl says it's good to go then it's time to peddle!

Wolves is being disingenuous. Doesn't like the fact this thing might actually work after all and could well be as good, if not better than was originally suggested. A product that turns out to be what it always said on the tin...if not better. Who'd of thunk it.

Dont know you from Adam so wont make a sweeping statement beyond what you write here which is idiotic agenda driven trash.